Literature DB >> 15582827

Neuropsychological outcome following focal cortical removal for intractable epilepsy in children.

Suncica Lah1.   

Abstract

In children, surgery for epilepsy has been recognized as a viable treatment option since publication of S. Davidson and M.A. Falconer's outcome study in 1975 [Lancet North Am Ed 5:1260-3], which demonstrated that medical outcome of children who underwent anterior temporal lobectomy paralleled that of adults. Pediatric surgical programs and the literature on medical outcome have grown considerably since that time, with surgery being offered to children with temporal but also extratemporal epilepsy foci. Comparatively little work has been conducted in the area of neuropsychological outcome. This article outlines differences in adult and pediatric outcome studies, reviews the literature on the intellectual and memory outcome in children, and discusses shortcomings of the pediatric outcome research conducted to date.

Entities:  

Mesh:

Year:  2004        PMID: 15582827     DOI: 10.1016/j.yebeh.2004.08.005

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  4 in total

1.  Age-dependent mesial temporal lobe lateralization in language fMRI.

Authors:  Leigh N Sepeta; Madison M Berl; Marko Wilke; Xiaozhen You; Meera Mehta; Benjamin Xu; Sara Inati; Irene Dustin; Omar Khan; Alison Austermuehle; William H Theodore; William D Gaillard
Journal:  Epilepsia       Date:  2015-12-23       Impact factor: 5.864

2.  Cognitive assessment in epilepsy surgery of children.

Authors:  D Battaglia; D Chieffo; D Lettori; F Perrino; C Di Rocco; F Guzzetta
Journal:  Childs Nerv Syst       Date:  2006-07-12       Impact factor: 1.475

Review 3.  Temporal lobe resections.

Authors:  William Harkness
Journal:  Childs Nerv Syst       Date:  2006-07-11       Impact factor: 1.475

Review 4.  Imaging episodic memory during development and childhood epilepsy.

Authors:  Leigh N Sepeta; Madison M Berl; William Davis Gaillard
Journal:  J Neurodev Disord       Date:  2018-12-13       Impact factor: 4.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.